Instead, strict pacing is required
Because IGF-1 can act on insulin receptors, its powerful, long-acting nature requires careful monitoring and control in any laboratory setting
Patients are given a loading dose and will have medication three times every two weeks for three doses and then once every four weeks afterwards
Ohlmann T
Ralf Grtner, Senior Vice President & General Manager, Corporate Performance Solutions at Wolters Kluwer CCH Tagetik, added: "This strategic partnership provides Wolters Kluwer with additional fuel to accelerate the rapid, global expansion of our comprehensive CCH Tagetik platform among LTIMindtree clients
This information is for educational and informational purposes only, and is not intended to diagnose, treat, cure or prevent any disease